NonExomics
Acton, US · Founded 2021 · 2 known investors
NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
Founders & leadership
NonExomics was founded in 2021 by Ruchi Chauhan.
RC
Ruchi ChauhanFounder
Investors · 2
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 round · 2021
▶$200KraisedApr 2021 · 1 investors · Other Health CareRule 506(b)
▶$200KraisedApr 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ruchi ChauhanDirector
- Offering amount
- $250K
- Amount sold
- $200K
- Minimum investment
- $1
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does NonExomics do?
- NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.
- Who founded NonExomics?
- NonExomics was founded by Ruchi Chauhan in 2021.
- Who are NonExomics's investors?
- NonExomics's investors include Illumina Accelerator, Formation Venture Engineering.
- How much funding has NonExomics raised?
- NonExomics has disclosed $200K raised across 1 round.
- Where is NonExomics headquartered?
- NonExomics is headquartered in Acton, US.